Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03137953Not ApplicableUnknown

Role of Imaging to Predict the Deep Surgical Margin in Gingivobuccal Complex Tumors

Role: lead

NCT03039465Not ApplicableUnknown

A Novel Modified Tracheo-Esophageal Voice Prosthesis for Total Laryngectomy Patients

Role: lead

NCT02985255Phase 2Unknown

Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

Role: lead

All 3 trials loaded